- Pegfilgrastim (subcutaneous route) - Side effects dosage
Pegfilgrastim helps the bone marrow to make new white blood cells When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight infections Pegfilgrastim is used to reduce the risk of infection while you are being treated with cancer medicines
- Pegfilgrastim - Wikipedia
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim [21]
- Pegfilgrastim Injection: Uses Side Effects - Cleveland Clinic
Pegfilgrastim is a medication that lowers your risk of developing an infection if you receive chemotherapy It works by helping your body make more white blood cells
- NEULASTA (pegfilgrastim) Label - Food and Drug Administration
Pegfilgrastim is a colony-stimulating factor that acts on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and
- Pegfilgrastim - NCI - National Cancer Institute
This page contains brief information about pegfilgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
- Pegfilgrastim Injection: MedlinePlus Drug Information
Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection)
- Pegfilgrastim (Fulphila, Neulasta, and Others) - Uses, Side . . . - WebMD
Pegfilgrastim is used to prevent infection in people with low levels of white blood cells called neutrophils It stimulates the bone marrow to make more neutrophils, which help fight infection in
- Neulasta (Pegfilgrastim): Side Effects, Uses, Dosage . . . - RxList
Neulasta (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection, by treating neutropenia, a lack of certain white blood cells caused by receiving cancer chemotherapy
|